Prognostic and Predictive Markers in Cancer

Por Conley, Barbara A., Taube, Sheila E.
Publicado em 2004

Novel Biochemical Pathways of Endoglin in Vascular Cell Physiology

Por Bernabeu, Carmelo, Conley, Barbara A., Vary, Calvin P.H.
Publicado em 2007

Designing biomarker studies for head and neck cancer

Por Kim, Kelly Y., McShane, Lisa M., Conley, Barbara A.
Publicado em 2014

Development and Use of Integral Assays in Clinical Trials

Por Schilsky, Richard L., Doroshow, James H., LeBlanc, Michael, Conley, Barbara A.
Publicado em 2012

Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use

Por Williams, P. Michael, Lively, Tracy G., Jessup, J. Milburn, Conley, Barbara A.
Publicado em 2012

Next-Generation Sequencing to Guide Clinical Trials

Por Siu, Lillian L., Conley, Barbara A., Boerner, Scott, LoRusso, Patricia M.
Publicado no Clin Cancer Res (2015)

AHNAK2 participates in the stress-induced nonclassical FGF1 secretion pathway

Por Kirov, Aleksandr, Kacer, Doreen, Conley, Barbara A., Vary, Calvin P.H., Prudovsky, Igor
Publicado no J Cell Biochem (2015)

Endoglin Plays Distinct Roles in Vascular Smooth Muscle Cell Recruitment and Regulation of Arteriovenous Identity During Angiogenesis

Por Mancini, Maria L., Terzic, Aleksandra, Conley, Barbara A., Oxburgh, Leif H., Nicola, Teodora, Vary, Calvin P.H.
Publicado em 2009

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration

Por Romero, Diana, Terzic, Aleksandra, Conley, Barbara A., Craft, Clarissa S., Jovanovic, Borko, Bergan, Raymond C., Vary, Calvin P.H.
Publicado em 2010

Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers

Por Polley, Mei-Yin C., Freidlin, Boris, Korn, Edward L., Conley, Barbara A., Abrams, Jeffrey S., McShane, Lisa M
Publicado em 2013

An unusual case of autoimmune pancreatitis presenting as pancreatic mass and obstructive jaundice: a case report and review of the literature

Por Efeovbokhan, Nephertiti, Makol, Ashima, Cuison, Reuben V, Minter, Rebecca M, Kotaru, Veera-Pavan, Conley, Barbara A, Chandana, Sreenivasa R
Publicado em 2011

Endoglin is required for myogenic differentiation potential of neural crest stem cells

Por Mancini, Maria L., Verdi, Joseph M., Conley, Barbara A., Nicola, Teodora, Spicer, Douglas B., Oxburgh, Leif H., Vary, Calvin P.H.
Publicado em 2007

Endoglin regulates cancer-stromal cell interactions in prostate tumors

Por Romero, Diana, O’Neill, Christine, Terzic, Aleksandra, Contois, Liangru, Young, Kira, Conley, Barbara A., Bergan, Raymond C., Brooks, Peter C., Vary, Calvin P.H.
Publicado em 2011

A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas

Por Kummar, Shivaani, Gutierrez, Martin E., Gardner, Erin R., Figg, William, Melillo, Giovanni, Dancey, Janet, Sausville, Edward A., Conley, Barbara A., Murgo, Anthony J., Doroshow, James H.
Publicado em 2009

Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers

Por Kummar, Shivaani, Williams, P. Mickey, Lih, Chih-Jian, Polley, Eric C., Chen, Alice P., Rubinstein, Larry V., Zhao, Yingdong, Simon, Richard M., Conley, Barbara A., Doroshow, James H.
Publicado no J Natl Cancer Inst (2015)

GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials

Por Zhao, Yingdong, Polley, Eric C, Li, Ming-Chung, Lih, Chih-Jian, Palmisano, Alida, Sims, David J, Rubinstein, Lawrence V, Conley, Barbara A, Chen, Alice P, Williams, P Mickey, Kummar, Shivaani, Doroshow, James H, Simon, Richard M
Publicado no Cancer Inform (2015)

Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays

Por Sims, David J., Harrington, Robin D., Polley, Eric C., Forbes, Thomas D., Mehaffey, Michele G., McGregor, Paul M., Camalier, Corinne E., Harper, Kneshay N., Bouk, Courtney H., Das, Biswajit, Conley, Barbara A., Doroshow, James H., Williams, P. Mickey, Lih, Chih-Jian
Publicado no J Mol Diagn (2016)

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

Por McShane, Lisa M, Cavenagh, Margaret M, Lively, Tracy G, Eberhard, David A, Bigbee, William L, Williams, P Mickey, Mesirov, Jill P, Polley, Mei-Yin C, Kim, Kelly Y, Tricoli, James V, Taylor, Jeremy MG, Shuman, Deborah J, Simon, Richard M, Doroshow, James H, Conley, Barbara A
Publicado em 2013

Criteria for the use of omics-based predictors in clinical trials

Por McShane, Lisa M., Cavenagh, Margaret M., Lively, Tracy G., Eberhard, David A., Bigbee, William L., Williams, P. Mickey, Mesirov, Jill P., Polley, Mei-Yin C., Kim, Kelly Y., Tricoli, James V., Taylor, Jeremy M. G., Shuman, Deborah J., Simon, Richard M., Doroshow, James H., Conley, Barbara A.
Publicado em 2013

Phase I Trial of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG), a Heat Shock Protein Inhibitor, Administered Twice Weekly in Patients with Advanced Malignancies

Por Kummar, Shivaani, Gutierrez, Martin E., Gardner, Erin R., Chen, Xiaohong, Figg, William D., Zajac-Kaye, Maria, Chen, Min, Steinberg, Seth M., Muir, Christine A., Yancey, Mary Ann, Horneffer, Yvonne R., Juwara, Lamin, Melillo, Giovanni, Ivy, S. Percy, Merino, Maria, Neckers, Len, Steeg, Patricia S., Conley, Barbara A., Giaccone, Giuseppe, Doroshow, James H., Murgo, Anthony J.
Publicado em 2009